Tenax Therapeutics Inc.

NASDAQ: TENX · Real-Time Price · USD
5.85
-0.10 (-1.68%)
At close: Aug 15, 2025, 1:09 PM

Tenax Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
94.85M 9.79M 2.12M 5.58M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a 1.12K 9.55K 8.44K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
64K 251.58K 345.86K n/a
Total Current Assets
96.69M 11.68M 3.21M 5.69M
Property-Plant & Equipment
n/a n/a 186.69K 294.8K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
n/a 1.12K 196.24K 303.24K
Total Assets
96.69M 11.68M 3.4M 5.99M
Account Payables
3.16M 2.07M 448.43K 859.64K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 500.9K 624.3K 107.19K
Other Current Liabilities
n/a 236.88K 245.39K -107.19K
Total Current Liabilities
4.69M 3.59M 1.85M 1.56M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 64.2K 183.59K
Total Liabilities
4.69M 3.59M 1.91M 1.75M
Total Debt
n/a 500.9K 807.89K 290.78K
Common Stock
n/a 30.00 4.58K 2.52K
Retained Earnings
-314.86M -297.25M -289.54M -278.49M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
91.99M 8.1M 1.49M 4.24M
Total Investments
n/a n/a n/a n/a